Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$2.94 - $4.75 $232,157 - $375,083
-78,965 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$3.99 - $5.53 $6,623 - $9,179
1,660 Added 2.15%
78,965 $340,000
Q4 2020

Feb 16, 2021

BUY
$2.99 - $5.79 $3,602 - $6,976
1,205 Added 1.58%
77,305 $301,000
Q3 2020

Nov 16, 2020

BUY
$4.79 - $9.1 $40,542 - $77,022
8,464 Added 12.51%
76,100 $375,000
Q2 2020

Aug 14, 2020

SELL
$3.61 - $11.84 $169,420 - $555,663
-46,931 Reduced 40.96%
67,636 $487,000
Q1 2020

May 14, 2020

SELL
$2.56 - $6.14 $1,922 - $4,611
-751 Reduced 0.65%
114,567 $480,000
Q3 2019

Nov 14, 2019

BUY
$6.55 - $9.36 $420,772 - $601,286
64,240 Added 125.77%
115,318 $951,000
Q2 2019

Aug 15, 2019

BUY
$5.92 - $9.47 $302,381 - $483,708
51,078 New
51,078 $480,000

Others Institutions Holding BSGM

About BioSig Technologies, Inc.


  • Ticker BSGM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 44,814,400
  • Market Cap $60.1M
  • Description
  • BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal ...
More about BSGM
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.